Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
A therapeutic approach in which a person’s immune cells are genetically recoded to enable them to target their cancerous cousins is helping people whose disease is beyond the reach of existing treatments.
Numerous treatment options have emerged for lymphomas, but there are still considerable challenges to be tackled to increase the chances of long-term survival.
Working as a scientist in low- and middle-income countries can be challenging, but it also provides the opportunity to make a difference to people’s lives.
Health-care providers in low- and middle-income countries are shifting their focus away from infections, and towards the bigger problems of diabetes and cardiovascular disease.